Profilo
Mark McDonnell currently works as a Chief Chemist at Neuropathix, Inc.
Posizioni attive di Mark McDonnell
| Società | Posizione | Inizio |
|---|---|---|
| NEUROPATHIX, INC. | Corporate Officer/Principal | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
8
Relazioni di 1° grado
1
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 1 |
|---|---|
Neuropathix, Inc.
 Neuropathix, Inc. Pharmaceuticals: MajorHealth Technology Neuropathix, Inc. is a biopharmaceutical company. It engages in the research and development of novel new therapeutic agents designed to reduce oxidative stress and act as immuno-modulators and neuroprotectants. The company was founded by Thoma Kikis in 2010 and is headquartered in Doylestown, PA. | Health Technology |
- Borsa valori
- Insiders
- Mark McDonnell
